Abu Dhabi, United Arab Emirates and Seoul, South Korea, June 29, 2026 (GLOBE NEWSWIRE) — Arcera Life Sciences (“Arcera”), a global life sciences company focused on advancing innovative and sustainable healthcare solutions, and Daewoong Pharmaceutical Co., Ltd. (“Daewoong”), a leading South Korean pharmaceutical company, today announced the expansion of their strategic partnership for Enavogliflozin, Daewoong’s novel sodium-glucose cotransporter-2 (SGLT2) inhibitor, into key markets across the Middle East.




![House of the Dragon season 3 episode 2 ending explained: Let’s talk about [SPOILERS] big death](https://dailynewsnblog.com/wp-content/uploads/2026/06/emma-d-arcy_0.jpg)

